228 related articles for article (PubMed ID: 28528797)
1. A case-control study of non-AIDS-defining cancers in a prospective cohort of HIV-infected patients.
Rodríguez Arrondo F; von Wichmann MÁ; Camino X; Goenaga MÁ; Ibarguren M; Azcune H; Bustinduy MJ; Ferrero O; Muñoz J; Ibarra S; Aguirrebengoa K; Goicoetxea J; Bereciartua E; Montejo M; García MA; Martínez E; Portu J; Metola L; Silvariño R; Sarasqueta C; Arrizabalaga J; Iribarren JA;
Med Clin (Barc); 2018 Apr; 150(8):291-296. PubMed ID: 28528797
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
3. Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico.
Cornejo-Juárez P; Cavildo-Jerónimo D; Volkow-Fernández P
AIDS Res Ther; 2018 Oct; 15(1):16. PubMed ID: 30368240
[TBL] [Abstract][Full Text] [Related]
4. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
[TBL] [Abstract][Full Text] [Related]
5. HIV infection and the risk of cancers with and without a known infectious cause.
Silverberg MJ; Chao C; Leyden WA; Xu L; Tang B; Horberg MA; Klein D; Quesenberry CP; Towner WJ; Abrams DI
AIDS; 2009 Nov; 23(17):2337-45. PubMed ID: 19741479
[TBL] [Abstract][Full Text] [Related]
6. Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors.
Petoumenos K; Hui E; Kumarasamy N; Kerr SJ; Choi JY; Chen YM; Merati T; Zhang F; Lim PL; Sungkanuparph S; Pujari S; Ponnampalavanar S; Ditangco R; Lee CK; Grulich A; Law MG;
J Int AIDS Soc; 2010 Dec; 13():51. PubMed ID: 21143940
[TBL] [Abstract][Full Text] [Related]
7. Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis.
Krishnan S; Schouten JT; Jacobson DL; Benson CA; Collier AC; Koletar SL; Santana J; Sattler FR; Mitsuyasu R;
Oncology; 2011; 80(1-2):42-9. PubMed ID: 21606663
[TBL] [Abstract][Full Text] [Related]
8. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
[TBL] [Abstract][Full Text] [Related]
9. The Pattern of Non-AIDS-defining Cancers in the HIV Population: Epidemiology, Risk Factors and Prognosis. A Review.
Franzetti M; Ricci E; Bonfanti P
Curr HIV Res; 2019; 17(1):1-12. PubMed ID: 30919779
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study.
Nagata N; Nishijima T; Niikura R; Yokoyama T; Matsushita Y; Watanabe K; Teruya K; Kikuchi Y; Akiyama J; Yanase M; Uemura N; Oka S; Gatanaga H
BMC Cancer; 2018 Nov; 18(1):1066. PubMed ID: 30400779
[TBL] [Abstract][Full Text] [Related]
11. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.
Worm SW; Bower M; Reiss P; Bonnet F; Law M; Fätkenheuer G; d'Arminio Monforte A; Abrams DI; Grulich A; Fontas E; Kirk O; Furrer H; De Wit S; Phillips A; Lundgren JD; Sabin CA;
BMC Infect Dis; 2013 Oct; 13():471. PubMed ID: 24106926
[TBL] [Abstract][Full Text] [Related]
12. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
[TBL] [Abstract][Full Text] [Related]
13. Nationwide Longitudinal Annual Survey of HIV/AIDS Referral Hospitals in Japan From 1999 to 2021: Trend in Non-AIDS-defining Cancers Among Individuals Infected With HIV-1.
Tanaka T; Oshima K; Kawano K; Tashiro M; Kakiuchi S; Tanaka A; Fujita A; Ashizawa N; Tsukamoto M; Yasuoka A; Teruya K; Izumikawa K
J Acquir Immune Defic Syndr; 2024 May; 96(1):1-10. PubMed ID: 38427920
[TBL] [Abstract][Full Text] [Related]
14. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
[TBL] [Abstract][Full Text] [Related]
15. Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
[TBL] [Abstract][Full Text] [Related]
16. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.
Crum-Cianflone N; Hullsiek KH; Marconi V; Weintrob A; Ganesan A; Barthel RV; Fraser S; Agan BK; Wegner S
AIDS; 2009 Jan; 23(1):41-50. PubMed ID: 19050385
[TBL] [Abstract][Full Text] [Related]
17. [Malignancy cases in HIV-positive patients in Lodz region in years 1992-2010].
Jabłonowska E; Małolepsza E; Strycharz M; Wójcik K
Przegl Epidemiol; 2011; 65(2):339-43. PubMed ID: 21913486
[TBL] [Abstract][Full Text] [Related]
18. Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.
Tanaka LF; Latorre MDRD; Gutierrez EB; Heumann C; Herbinger KH; Froeschl G
Int J STD AIDS; 2017 Oct; 28(12):1190-1198. PubMed ID: 28178892
[TBL] [Abstract][Full Text] [Related]
19. Virologic and Immunologic Outcomes in HIV-Infected Patients with Cancer.
Riedel DJ; Stafford KA; Vadlamani A; Redfield RR
AIDS Res Hum Retroviruses; 2017 May; 33(5):482-489. PubMed ID: 27824263
[TBL] [Abstract][Full Text] [Related]
20. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
